INTEGRA LIFESCIENCES HOLDINGS CORPIART财报
Nasdaq · health technology
Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery. Integra artificial skin became the first commercially reproducible skin tissue used to treat severe burns and other skin wounds.
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| BlackRock, Inc. | 14.30% | 11.3M | ▲ +5.80pp | 2024-07-08 |
| The Vanguard Group | 10.06% | 7.8M | ▲ +1.09pp | 2024-08-12 |
| Fuller & Thaler Asset Management, Inc. | 5.11% | 4.0M | — | 2024-11-12 |
| Wellington Management Group LLP | 4.28% | 3.3M | — | 2024-02-09 |
| Champlain Investment Partners, LLC | 3.12% | 2.4M | — | 2024-02-13 |
| OF ABOVE PERSONS | 1.70% | 1.3M | ▼ -3.80pp | 2024-11-12 |
内部人交易
Net 90d: +$0 · buys $0 / sells $0时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-03-11 | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Option exercise | 18.9K | $0.00 | $0 |
| 2026-03-10 | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Option exercise | 1.2K | $0.00 | $0 |
1–2 of 2